State Ledger
Company profile

Dogwood Therapeutics, Inc. CIK 1818844

Ticker
DWTX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Alpharetta, GA 30009
Fiscal year end
2025 (FY)
Market Data
Close
$1.42
Change
-$0.01
Change %
-0.70%
Volume
904

DWTX · trading date Oct 9, 2026 · previous close $1.43 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$34.26M
Total assets
$90.17M
Total liabilities
$15.27M
Stockholders' equity
$74.90M
Cash & equivalents
$6.52M
Operating income
-$27.97M
Operating cash flow
-$15.62M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
16.9%
Equity / assets
83.1%
CapEx / revenue
—
Operating cash flow / net income
0.46×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$34.26M $90.17M $15.27M $74.90M
2024 — -$12.35M $94.31M $30.03M -$10.12M
2023 — -$5.30M $4.17M $358.5K $3.81M
2022 — -$12.25M $8.37M $1.04M $7.33M
2021 — -$15.96M $15.78M $1.28M $14.50M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Alpharetta, GA 30009
44 MILTON AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:28 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Georgia — Public Companies